These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

75 related articles for article (PubMed ID: 7132764)

  • 41. Isolation and structure of two prostaglandin endoperoxides that cause platelet aggregation.
    Hamberg M; Svensson J; Wakabayashi T; Samuelsson B
    Proc Natl Acad Sci U S A; 1974 Feb; 71(2):345-9. PubMed ID: 4521806
    [TBL] [Abstract][Full Text] [Related]  

  • 42. An enzyme isolated from arteries transforms prostaglandin endoperoxides to an unstable substance that inhibits platelet aggregation.
    Moncada S; Gryglewski R; Bunting S; Vane JR
    Nature; 1976 Oct; 263(5579):663-5. PubMed ID: 802670
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Nonenzymatic reduction of prostaglandin H by lipoic acid.
    Marnett LJ; Bienkowski MJ
    Biochemistry; 1977 Sep; 16(19):4303-7. PubMed ID: 332228
    [TBL] [Abstract][Full Text] [Related]  

  • 44. A structural requirement for the conversion of prostaglandin endoperoxides to thromboxanes.
    Diczfalusy U; Hammarström S
    FEBS Lett; 1979 Sep; 105(2):291-5. PubMed ID: 488357
    [No Abstract]   [Full Text] [Related]  

  • 45. Characterization of thromboxane A2/prostaglandin H2 (TXA2/PGH2) receptors of rat platelets and their interaction with TXA2/PGH2 receptor antagonists.
    Hanasaki K; Arita H
    Biochem Pharmacol; 1988 Oct; 37(20):3923-9. PubMed ID: 2973322
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Regulation of lymphatic contractility by arachidonate metabolites.
    Johnston MG; Gordon JL
    Nature; 1981 Sep; 293(5830):294-7. PubMed ID: 7196995
    [No Abstract]   [Full Text] [Related]  

  • 47. Transformations of prostaglandin H2 in the cat brain.
    Bishai I; Coceani F
    Biochim Biophys Acta; 1981 Apr; 664(1):1-9. PubMed ID: 6894549
    [TBL] [Abstract][Full Text] [Related]  

  • 48. What is the fate of exogenous prostaglandin endoperoxide, PGH2, in isolated lung? [proceedings].
    Al-Ubaidi F; Bakhle YS
    J Physiol; 1979 Aug; 293():20P-21P. PubMed ID: 501589
    [No Abstract]   [Full Text] [Related]  

  • 49. Action of prostaglandins, endoperoxides, and thromboxanes on the lamb ductus arteriosus.
    Coceani F; Bishai I; White E; Bodach E; Olley PM
    Am J Physiol; 1978 Feb; 234(2):H117-22. PubMed ID: 623311
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Role of prostaglandin synthesis in rabbit platelet activation induced by basophil-derived platelet-activating factor.
    Shaw JO; Printz MP; Hirabayashi K; Henson PM
    J Immunol; 1978 Nov; 121(5):1939-45. PubMed ID: 712073
    [No Abstract]   [Full Text] [Related]  

  • 51. Cerebral arteriolar damage by arachidonic acid and prostaglandin G2.
    Kontos HA; Wei EP; Povlishock JT; Dietrich WD; Magiera CJ; Ellis EF
    Science; 1980 Sep; 209(4462):1242-5. PubMed ID: 7403881
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Polymyxin B increases TXA2/PGH2 agonist and antagonist affinities in human platelet membranes.
    Halushka PV; Boehm A; Mais DE
    Eicosanoids; 1988; 1(1):41-4. PubMed ID: 2856171
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Role of endoperoxides in arachidonic acid-induced vasoconstriction in the isolated perfused kidney of the rat.
    Quilley J; McGiff JC; Nasjletti A
    Br J Pharmacol; 1989 Jan; 96(1):111-6. PubMed ID: 2522332
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Interactions between stimulated platelets and endothelial cells in vitro.
    Marcus AJ; Broekman MJ; Weksler BB; Jaffe EA; Safier LB; Ullman HL; Tack-Goldman K
    Philos Trans R Soc Lond B Biol Sci; 1981 Aug; 294(1072):343-53. PubMed ID: 6117896
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Reactions of prostaglandin endoperoxides with prostaglandin I synthetase solubilized from rabbit aorta microsomes.
    Watanabe K; Yamamoto S; Hayaishi O
    Biochem Biophys Res Commun; 1979 Mar; 87(1):192-9. PubMed ID: 110324
    [No Abstract]   [Full Text] [Related]  

  • 56. Platelet thromboxane A2/endoperoxide (TXA2/PGH2) receptors in type I diabetes mellitus.
    Jaschonek K; Faul C; Weisenberger H; Krönert K; Schröder H; Renn W
    Thromb Haemost; 1989 Jun; 61(3):535-6. PubMed ID: 2529665
    [No Abstract]   [Full Text] [Related]  

  • 57. Stimulation of prostacyclin production by vitamin C in ram seminal vesicle microsomes: possible mode of action.
    Beetens JR; Van Hoydonck AE; Herman AG
    Arch Int Pharmacodyn Ther; 1985 Sep; 277(1):56-65. PubMed ID: 3904652
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effects of OKY 1581 on bronchoconstrictor responses to arachidonic acid and PGH2.
    Tilden SJ; Underwood DC; Cowen KH; Wegmann MJ; Graybar GB; Hyman AL; McNamara DB; Kadowitz PJ
    J Appl Physiol (1985); 1987 May; 62(5):2066-74. PubMed ID: 2954941
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prostaglandin H2 in human platelet activation: coactivator and substitute for thromboxane A2.
    Hornberger WB; Patscheke H
    Prog Clin Biol Res; 1989; 301():315-9. PubMed ID: 2798452
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Responses to prostaglandins H2 and I2 of isolated dog cerebral and peripheral arteries.
    Toda N
    Am J Physiol; 1980 Feb; 238(2):H111-7. PubMed ID: 6987901
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.